A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

Launched by CLOUDCATH · Mar 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a device called CloudCath, which aims to help detect infections related to peritoneal dialysis (a treatment for patients with end-stage kidney disease) more quickly and effectively than current methods. The study will see if this device can identify signs of peritonitis, an infection that can occur in patients using peritoneal dialysis, as fast or faster than what is currently done.

To participate in this study, you need to be using peritoneal dialysis and able to provide your consent to join. You should also have a good cellular data connection at home, as some of the study's activities may require it. However, if you have had certain health issues recently, such as an active infection or a diagnosis of peritonitis, or if you're involved in another clinical trial, you may not be eligible. If you decide to take part, you can expect to follow specific requirements outlined by the study team, who will guide you through the process. This research could help improve how infections are detected in patients undergoing peritoneal dialysis.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • currently using peritoneal dialysis
• • provides informed consent
• • willing to comply with the requirements of the study
• • has cellular data coverage at home
• Key Exclusion Criteria:
• • active or history of cancer requiring chemotherapy within prior 6 months
• • signs or symptoms of an active infection within 14 days prior to enrollment
• • peritonitis diagnosis within 30 days prior to enrollment
• • participating in another investigational device or drug study that may potentially affect study results
• • other medical, social or psychological problems that, in the opinion of the investigator, exclude the study participant from the study